Yash Optics & Lens Ltd.
•₹ 115.455.43%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 35.4%
- Company has a healthy return on capital (ROCE) of 34.4%
- Company comfortably covers its interest (11.6x coverage)
- Company maintains a comfortable, low leverage position
CONS
- Receivables are growing faster than sales - a possible quality concern
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.71x)
- Operating cash flow has been negative in recent years
- Working capital days have increased from 176 to 524 days
- Free cash flow has been persistently negative
- Operating margins have contracted to 29.1% from 34.7%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | LENSKART | 654.40 | 173.67 | 113820.20 | 0.00 | 2284.30 | 3634.35 | 27141.80 | 1332.69 | 12.55 | 21.70 |
| 2. | POLYMED | 1766.40 | 56.82 | 17904.49 | 0.20 | 85.27 | -8.39 | 525.38 | 30.30 | 14.05 | 24.11 |
| 3. | MOLBIO | 1032.40 | 71.42 | 11897.38 | 0.00 | — | — | — | — | 19.79 | — |
| 4. | LAXMIDENTL | 199.35 | 35.51 | 1096.85 | 0.00 | 10.32 | 23.83 | 74.70 | 16.13 | 24.96 | 20.26 |
| 5. | 3BBLACKBIO | 1138.50 | 17.60 | 977.14 | 0.44 | 8.98 | -28.99 | 33.49 | 50.59 | 26.03 | 25.45 |
| 6. | YASHOPTICS | 109.50 | 0.00 | 271.18 | 0.46 | — | — | — | — | 17.76 | — |
| 7. | GKB | 61.90 | 9.62 | 31.20 | 0.00 | 1.85 | 387.99 | 33.04 | 2.26 | 8.82 | 7.97 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 15 | 30 | 40 | 41 | 43 | |
| 13 | 20 | 27 | 27 | 31 | |
| Operating Profit | 2 | 10 | 13 | 15 | 15 |
| OPM % | 14 | 35 | 32 | 36 | 36 |
| Other Income | 0 | 0 | 0 | 0 | 3 |
| Interest | 1 | 1 | 1 | 2 | 1 |
| Depreciation | 0 | 1 | 1 | 1 | 1 |
| 1 | 9 | 11 | 12 | 13 | |
| Tax % | 28 | 26 | 26 | 26 | 26 |
| Net Profit | 1 | 7 | 8 | 9 | 10 |
| EPS | 1 | 4 | 8,028 | 5 | 4 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | 4 | 5 | 5 | 4 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | 4 | 5 | 5 | 4 |
Mar 2021
- 15
- 13
- Operating Profit
- 2
- OPM %
- 14
- Other Income
- 0
- Interest
- 1
- Depreciation
- 0
- 1
- Tax %
- 28
- Net Profit
- 1
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2022
- 30
- 20
- Operating Profit
- 10
- OPM %
- 35
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 9
- Tax %
- 26
- Net Profit
- 7
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2023
- 40
- 27
- Operating Profit
- 13
- OPM %
- 32
- Other Income
- 0
- Interest
- 1
- Depreciation
- 1
- 11
- Tax %
- 26
- Net Profit
- 8
- EPS
- 8,028
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2024
- 41
- 27
- Operating Profit
- 15
- OPM %
- 36
- Other Income
- 0
- Interest
- 2
- Depreciation
- 1
- 12
- Tax %
- 26
- Net Profit
- 9
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2025
- 43
- 31
- Operating Profit
- 15
- OPM %
- 36
- Other Income
- 3
- Interest
- 1
- Depreciation
- 1
- 13
- Tax %
- 26
- Net Profit
- 10
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 13%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 12%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 1%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 44%
- 3 Years:
- 35%
- Last Year:
- 16%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - |
| Equity Capital | 0 | 0 | 0 | 18 | 25 |
| 4 | 11 | 19 | 12 | 66 | |
| 0 | 0 | 0 | 2 | 2 | |
| Trade Payables | 2 | 8 | 3 | 4 | 5 |
| 6 | 5 | 12 | 25 | 15 | |
| Total Liabilities | 12 | 24 | 34 | 61 | 112 |
| ASSETS | - | - | - | - | - |
| 0 | 4 | 8 | 19 | 30 | |
| Capital Work in Progress | 0 | 0 | 0 | 6 | 3 |
| 6 | 11 | 16 | 20 | 22 | |
| 0 | 0 | 0 | 12 | 16 | |
| Cash & Bank | 1 | 1 | 1 | 1 | 32 |
| 5 | 8 | 10 | 2 | 10 | |
| Total Assets | 12 | 24 | 34 | 61 | 112 |
| Total Debt | 6 | 4 | 11 | 25 | 15 |
| Net Working Capital | 10 | 11 | 22 | 20 | 62 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 4266.00 | 11049.20 | 19045.60 | 16.39 | 36.49 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 6 | 4 | 11 | 25 | 15 |
| Net Working Capital | 10 | 11 | 22 | 20 | 62 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 4266.00 | 11049.20 | 19045.60 | 16.39 | 36.49 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2021
- Equity Capital
- 0
- 4
- 0
- Trade Payables
- 2
- 6
- Total Liabilities
- 12
- 0
- Capital Work in Progress
- 0
- 6
- 0
- Cash & Bank
- 1
- 5
- Total Assets
- 12
- Total Debt
- 6
- Net Working Capital
- 10
- Contingent Liabilities
- 0
- Book Value per Share
- 4266.00
- Face Value
- 10.00
- Total Debt
- 6
- Net Working Capital
- 10
- Contingent Liabilities
- 0
- Book Value per Share
- 4266.00
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 0
- 11
- 0
- Trade Payables
- 8
- 5
- Total Liabilities
- 24
- 4
- Capital Work in Progress
- 0
- 11
- 0
- Cash & Bank
- 1
- 8
- Total Assets
- 24
- Total Debt
- 4
- Net Working Capital
- 11
- Contingent Liabilities
- 0
- Book Value per Share
- 11049.20
- Face Value
- 10.00
- Total Debt
- 4
- Net Working Capital
- 11
- Contingent Liabilities
- 0
- Book Value per Share
- 11049.20
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 0
- 19
- 0
- Trade Payables
- 3
- 12
- Total Liabilities
- 34
- 8
- Capital Work in Progress
- 0
- 16
- 0
- Cash & Bank
- 1
- 10
- Total Assets
- 34
- Total Debt
- 11
- Net Working Capital
- 22
- Contingent Liabilities
- 0
- Book Value per Share
- 19045.60
- Face Value
- 10.00
- Total Debt
- 11
- Net Working Capital
- 22
- Contingent Liabilities
- 0
- Book Value per Share
- 19045.60
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 18
- 12
- 2
- Trade Payables
- 4
- 25
- Total Liabilities
- 61
- 19
- Capital Work in Progress
- 6
- 20
- 12
- Cash & Bank
- 1
- 2
- Total Assets
- 61
- Total Debt
- 25
- Net Working Capital
- 20
- Contingent Liabilities
- 0
- Book Value per Share
- 16.39
- Face Value
- 10.00
- Total Debt
- 25
- Net Working Capital
- 20
- Contingent Liabilities
- 0
- Book Value per Share
- 16.39
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 25
- 66
- 2
- Trade Payables
- 5
- 15
- Total Liabilities
- 112
- 30
- Capital Work in Progress
- 3
- 22
- 16
- Cash & Bank
- 32
- 10
- Total Assets
- 112
- Total Debt
- 15
- Net Working Capital
- 62
- Contingent Liabilities
- 0
- Book Value per Share
- 36.49
- Face Value
- 10.00
- Total Debt
- 15
- Net Working Capital
- 62
- Contingent Liabilities
- 0
- Book Value per Share
- 36.49
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -0 | 8 | -12 | -12 | 6 | |
| Cash from Investing | -0 | -5 | -8 | -19 | -37 |
| Cash from Financing | 0 | -2 | 10 | 31 | 31 |
| 0 | 0 | -11 | 0 | -0 | |
| Free Cash Flow | -0 | 3 | -18 | -31 | -3 |
| OCF / Net Profit | -0.05 | 1.13 | -1.51 | -1.37 | 0.59 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
| OCF / Net Profit | -0.05 | 1.13 | -1.51 | -1.37 | 0.59 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
Mar 2021
- -0
- Cash from Investing
- -0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- -0
- OCF / Net Profit
- -0.05
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.05
- Cumulative 5-Year FCF
- 0
Mar 2022
- 8
- Cash from Investing
- -5
- Cash from Financing
- -2
- 0
- Free Cash Flow
- 3
- OCF / Net Profit
- 1.13
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.13
- Cumulative 5-Year FCF
- 0
Mar 2023
- -12
- Cash from Investing
- -8
- Cash from Financing
- 10
- -11
- Free Cash Flow
- -18
- OCF / Net Profit
- -1.51
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.51
- Cumulative 5-Year FCF
- 0
Mar 2024
- -12
- Cash from Investing
- -19
- Cash from Financing
- 31
- 0
- Free Cash Flow
- -31
- OCF / Net Profit
- -1.37
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -1.37
- Cumulative 5-Year FCF
- 0
Mar 2025
- 6
- Cash from Investing
- -37
- Cash from Financing
- 31
- -0
- Free Cash Flow
- -3
- OCF / Net Profit
- 0.59
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.59
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - |
| EPS (₹) | 1063.10 | 6816.70 | 8028.00 | 4.96 | 3.87 |
| Book Value (₹) | 4266.00 | 11049.20 | 19045.60 | 16.39 | 36.49 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.65 | 4.19 | 4.93 | 5.44 | 4.36 |
| PROFITABILITY | - | - | - | - | - |
| Operating Margin % | 13.87% | 34.72% | 31.64% | 35.52% | 29.12% |
| Net Margin % | 7.11% | 22.91% | 20.22% | 21.95% | 22.19% |
| ROE % | 24.92% | 89.02% | 53.35% | 36.92% | 15.95% |
| ROCE % | 19.68% | 77.15% | 52.78% | 32.53% | 17.76% |
| 8.78% | 37.30% | 27.45% | 19.07% | 11.11% | |
| EFFICIENCY | - | - | - | - | - |
| Debtor Days | 100 | 73 | 78 | 93 | 116 |
| Inventory Days | 152 | 103 | 120 | 158 | 178 |
| Payable Days | 57 | 164 | 125 | 94 | 108 |
| 194 | 11 | 73 | 157 | 185 | |
| FINANCIAL HEALTH | - | - | - | - | - |
| Debt to Equity (x) | 1.37x | 0.36x | 0.57x | 0.85x | 0.16x |
| Interest Coverage (x) | 3.95x | 17.49x | 11.67x | 8.11x | 11.59x |
| 6.49x | 2.19x | 7.48x | 2.49x | 8.50x | |
| GROWTH | - | - | - | - | - |
| Revenue Growth % | 0.00% | 98.84% | 33.45% | 3.55% | 5.10% |
| Operating Profit Growth % | 0.00% | 397.60% | 21.64% | 16.99% | 4.91% |
| Net Profit Growth % | 0.00% | 541.21% | 17.77% | 12.39% | 6.27% |
| 0.00% | 0.00% | 0.00% | -99.94% | -21.89% | |
| VALUATION | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 20.72x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 2.20x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 2.90x | 11.77x |
Mar 2021
- EPS (₹)
- 1063.10
- Book Value (₹)
- 4266.00
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.65
- Operating Margin %
- 13.87%
- Net Margin %
- 7.11%
- ROE %
- 24.92%
- ROCE %
- 19.68%
- 8.78%
- Debtor Days
- 100
- Inventory Days
- 152
- Payable Days
- 57
- 194
- Debt to Equity (x)
- 1.37x
- Interest Coverage (x)
- 3.95x
- 6.49x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 6816.70
- Book Value (₹)
- 11049.20
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.19
- Operating Margin %
- 34.72%
- Net Margin %
- 22.91%
- ROE %
- 89.02%
- ROCE %
- 77.15%
- 37.30%
- Debtor Days
- 73
- Inventory Days
- 103
- Payable Days
- 164
- 11
- Debt to Equity (x)
- 0.36x
- Interest Coverage (x)
- 17.49x
- 2.19x
- Revenue Growth %
- 98.84%
- Operating Profit Growth %
- 397.60%
- Net Profit Growth %
- 541.21%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 8028.00
- Book Value (₹)
- 19045.60
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.93
- Operating Margin %
- 31.64%
- Net Margin %
- 20.22%
- ROE %
- 53.35%
- ROCE %
- 52.78%
- 27.45%
- Debtor Days
- 78
- Inventory Days
- 120
- Payable Days
- 125
- 73
- Debt to Equity (x)
- 0.57x
- Interest Coverage (x)
- 11.67x
- 7.48x
- Revenue Growth %
- 33.45%
- Operating Profit Growth %
- 21.64%
- Net Profit Growth %
- 17.77%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 4.96
- Book Value (₹)
- 16.39
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.44
- Operating Margin %
- 35.52%
- Net Margin %
- 21.95%
- ROE %
- 36.92%
- ROCE %
- 32.53%
- 19.07%
- Debtor Days
- 93
- Inventory Days
- 158
- Payable Days
- 94
- 157
- Debt to Equity (x)
- 0.85x
- Interest Coverage (x)
- 8.11x
- 2.49x
- Revenue Growth %
- 3.55%
- Operating Profit Growth %
- 16.99%
- Net Profit Growth %
- 12.39%
- -99.94%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 2.90x
Mar 2025
- EPS (₹)
- 3.87
- Book Value (₹)
- 36.49
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.36
- Operating Margin %
- 29.12%
- Net Margin %
- 22.19%
- ROE %
- 15.95%
- ROCE %
- 17.76%
- 11.11%
- Debtor Days
- 116
- Inventory Days
- 178
- Payable Days
- 108
- 185
- Debt to Equity (x)
- 0.16x
- Interest Coverage (x)
- 11.59x
- 8.50x
- Revenue Growth %
- 5.10%
- Operating Profit Growth %
- 4.91%
- Net Profit Growth %
- 6.27%
- -21.89%
- P/E (x)
- 20.72x
- P/B (x)
- 2.20x
- Dividend Yield %
- 0.00%
- 11.77x
Documents
Announcements
Nothing filed yet.
Annual Reports
Credit Ratings
Nothing filed yet.